Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-7113b vs IR oxycodone in opioid‑naive cancer pain
jRCT2080222289Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydromorphone in cancer pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080222289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222289.